ARCHIVES

FDA Expands Gleevec Indication For Children with Ph+ ALL

This article is from The Cancer Letter archive.

Vol. 36 No. 1 | January 25, 2013

Download PDF Visit The Full Archive

Related Articles

Afinitor Tablet Doubles PFS; Lowers Progression Risk 65%

February 25, 2011

Gene Vector Labs Seek Vector Producers

February 23, 1996

Managed Care: Cancer Panel Finds Need “Critical” For Cost, Outcomes Data

September 13, 1996

ASCO Foundation Raised $200,000 In Its First Year.

June 2, 2000

NIH reiterates Position On Closed Meeting Of BSC Chairmen

September 23, 1994

Cancer Policy: President’s Cancer Panel Issues Statement On National Cancer Program

September 17, 1999